Ultiva® (remifentanil hydrochloride), intravenous dose of 2mg, 5mg: pharmacological and clinical profile
نویسندگان
چکیده
منابع مشابه
Buspirone Hydrochloride 7-5mg
Buspirone hydrochloride is supplied as tablets for oral administration containing 5 mg, 7.5 mg, 10 mg or 15 mg of buspirone hydrochloride USP. The 5 mg and 10 mg tablets are scored so they can be bisected. Thus, the 5 mg tablet can also provide a 2.5 mg dose, and the 10 mg tablet can provide a 5 mg dose. The 15 mg tablet is scored so it can be either bisected or trisected. Thus, a single tablet...
متن کاملPhase I and clinical pharmacological evaluation of pirozantrone hydrochloride (oxantrazole).
Pirozantrone hydrochloride, an anthrapyrazole analogue, was selected for clinical evaluation based on broad antitumor activity against murine tumor systems and on potentially less cardiotoxicity when compared to anthracyclines. This anthrapyrazole analogue is currently under clinical evaluation, and we now report results on a Phase I clinical trial incorporating a pharmacologically guided dose-...
متن کاملRanitidine hydrochloride: An update on analytical, clinical and pharmacological aspects
Ranitidine hydrochloride has been extensively used in the treatment of diverse gastrointestinal disorders. This drug is a selective, competitive histamine H2-receptor antagonist and established as a potent inhibitor of gastric acid secretion. Owing to its favourable efficacy and tolerability profiles, this drug has emerged as a first-line agent when suppression of gastric acid secretion is indi...
متن کاملClinical pharmacokinetic and pharmacodynamic profile of cinacalcet hydrochloride.
Cinacalcet hydrochloride (cinacalcet) is a calcimimetic approved for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD) receiving dialysis and for the treatment of hypercalcaemia in patients with parathyroid carcinoma. Following oral administration, peak plasma concentrations of cinacalcet occur within 2-6 hours. The absolute bioavailability is 20-25%, ...
متن کاملGlycopeptides in clinical development: pharmacological profile and clinical perspectives.
Vancomycin and teicoplanin are the two glycopeptides currently used in the clinics for the treatment of multiresistant infections by Gram-positive organisms. The development of resistance in enterococci and staphylococci has stimulated the search for new derivatives with improved activity, particularly against strains resistant to conventional derivatives. Three of these, obtained by hemi-synth...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Folia Pharmacologica Japonica
سال: 2007
ISSN: 0015-5691,1347-8397
DOI: 10.1254/fpj.130.321